Categories
Posts
- Sima Lev – Advanced Science 2024 Programming a Ferroptosis – to – Apoptosis Transition. Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy.
- Sima Lev reccomends: Regulation of the epithelial control gene p63 by oncogenes and the Hippo signaling pathway
- Sima lev recommend: PYK2, a hub of signaling networks in breast cancer progression
- Sima lev recommend: Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
- Sima lev recommend: Updates in Triple-Negative Breast Cancer Treatment
- Sima Lev’s lab – Combination Therapy & Drug Resistance
- Treatment advances in metastatic triple-negative breast cancer (TNBC): Addressing the knowledge gap
- Researchers identify regulator of breast cancer development
- Accelerating AXL targeting for TNBC therapy Lohit Khera, Sima Lev
- The Golgi Apparatus and Membrane Contact Sites
- Sima Lev recommend-Webiner for Immuno-Oncology
- Tethering the assembly of SNARE complexes
- Animal Lectin Galectin 8 – By Hadas Shatz-Azoulay, Yaron Vinik, Roi Isaac, Ulrike Kohler, Sima Lev, Yehiel Zick
- Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
- Weizmann Institute of Science April 2020 Magazine
- Sima Lev – The COG complex and SNARE
- Three lectures by Robert Weinberg, a Professor for Cancer Research at MIT.
- Nir2 expression modulates cell morphology
- Nir2 regulates cell migration and invasion
- Epithelial-Mesenchymal Transition: EMT
- Cell Death & Disease: PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
- Epithelial-mesenchymal transition (EMT)
- Epithelial mesenchymal transition (EMT)
- Lipid transfer proteins in cancer biology & metastasis